Doxycycline reduces osteopenia in female rats

Detalhes bibliográficos
Autor(a) principal: Figueiredo, Fellipe A. T. de
Data de Publicação: 2019
Outros Autores: Shimano, Roberta C., Ervolino, Edilson [UNESP], Pitol, Dimitrius L., Gerlach, Raquel F., Issa, Joao Paulo M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1038/s41598-019-51702-y
http://hdl.handle.net/11449/196276
Resumo: Doxycycline, a member of the tetracycline family, is a drug used as an antibiotic (dosage of 100 mg/day) and as an anti-inflammatory drug on the dosage of 20 mg twice a day, this use has Matrix Metalloproteinases (MMP) inhibitor action. Doxycycline is a calcium chelator and therefore interferes in bone remodeling. The main objective of this study was to evaluate the action of the drug doxycycline in the control of osteopenia. Sixty three Wistars rats were divided into 9 groups with n=7 each, as follow: the control group with doxycycline 10 mg/kg/day (C10), control with doxycycline 30 mg/kg/day (C30) and control (C), ovariectomized group with doxycycline 10 mg/kg/day (OVX10), ovariectomized with doxycycline 30 mg/kg/day (OVX30), and ovariectomized with water (OVX), sedentary group with 10 mg/kg/day (Se10), sedentary with doxycycline 30 mg/kg/day (Se30), and sedentary group with water (Se). Left femoral bone was used for bone densitometry, right femoral bone for histological analysis. The right tibia was intended for chemical quantifications, the total serum was used for cholesterol and calcium quantification. The length of the left femoral bone was measured after the densitometry analysis. Statistical analysis was performed using multivariate general linear model (ANOVA two factors with Bonferroni adjustment) and the TRAP analysis was subjected to normality test and then were subjected to nonparametric test, both with p < 0.05 significance. Statistically significant differences were found, with better results for the groups exposed to the medication (10 and 30 mg/kg/day): Se vs. Se10 and Se vs. Se30 for BMC, quantification of magnesium, amount of cancellous bone in the distal portion; OVX vs. OVX10 for BMC, BMD and calcium in serum; OVX vs. OVX10 and OVX30 for quantification in proximal and distal portion of cancellous bone; Se vs. Se30 and OVX vs. OVX30 for immunostaining for TRAP, all results with minimum of p <= 0.05. Doxycycline had a deleterious effect on control groups and positive action for bone organization on female rats affected by bilateral ovariectomy-induced osteopenia and sedentary lifestyle.
id UNSP_fdd4e6e040a40c4cb5c97ea93fe0a0b2
oai_identifier_str oai:repositorio.unesp.br:11449/196276
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Doxycycline reduces osteopenia in female ratsDoxycycline, a member of the tetracycline family, is a drug used as an antibiotic (dosage of 100 mg/day) and as an anti-inflammatory drug on the dosage of 20 mg twice a day, this use has Matrix Metalloproteinases (MMP) inhibitor action. Doxycycline is a calcium chelator and therefore interferes in bone remodeling. The main objective of this study was to evaluate the action of the drug doxycycline in the control of osteopenia. Sixty three Wistars rats were divided into 9 groups with n=7 each, as follow: the control group with doxycycline 10 mg/kg/day (C10), control with doxycycline 30 mg/kg/day (C30) and control (C), ovariectomized group with doxycycline 10 mg/kg/day (OVX10), ovariectomized with doxycycline 30 mg/kg/day (OVX30), and ovariectomized with water (OVX), sedentary group with 10 mg/kg/day (Se10), sedentary with doxycycline 30 mg/kg/day (Se30), and sedentary group with water (Se). Left femoral bone was used for bone densitometry, right femoral bone for histological analysis. The right tibia was intended for chemical quantifications, the total serum was used for cholesterol and calcium quantification. The length of the left femoral bone was measured after the densitometry analysis. Statistical analysis was performed using multivariate general linear model (ANOVA two factors with Bonferroni adjustment) and the TRAP analysis was subjected to normality test and then were subjected to nonparametric test, both with p < 0.05 significance. Statistically significant differences were found, with better results for the groups exposed to the medication (10 and 30 mg/kg/day): Se vs. Se10 and Se vs. Se30 for BMC, quantification of magnesium, amount of cancellous bone in the distal portion; OVX vs. OVX10 for BMC, BMD and calcium in serum; OVX vs. OVX10 and OVX30 for quantification in proximal and distal portion of cancellous bone; Se vs. Se30 and OVX vs. OVX30 for immunostaining for TRAP, all results with minimum of p <= 0.05. Doxycycline had a deleterious effect on control groups and positive action for bone organization on female rats affected by bilateral ovariectomy-induced osteopenia and sedentary lifestyle.Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biomech Med & Rehabil Locomotor Syst, Av Dos Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, BrazilSao Paulo State Univ Julio de Mesquita Filho, Dept Basic Sci, R Jose Bonifacio 1193, BR-16015050 Aracatuba, SP, BrazilUniv Sao Paulo, Sch Dent Ribeirao Preto, Dept Basic & Oral Biol, Av Cafe S-N, BR-14040904 Ribeirao Preto, SP, BrazilSao Paulo State Univ Julio de Mesquita Filho, Dept Basic Sci, R Jose Bonifacio 1193, BR-16015050 Aracatuba, SP, BrazilNature Publishing GroupUniversidade de São Paulo (USP)Universidade Estadual Paulista (Unesp)Figueiredo, Fellipe A. T. deShimano, Roberta C.Ervolino, Edilson [UNESP]Pitol, Dimitrius L.Gerlach, Raquel F.Issa, Joao Paulo M.2020-12-10T19:39:23Z2020-12-10T19:39:23Z2019-10-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article14http://dx.doi.org/10.1038/s41598-019-51702-yScientific Reports. London: Nature Publishing Group, v. 9, 14 p., 2019.2045-2322http://hdl.handle.net/11449/19627610.1038/s41598-019-51702-yWOS:000492825800026Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengScientific Reportsinfo:eu-repo/semantics/openAccess2024-09-19T14:02:54Zoai:repositorio.unesp.br:11449/196276Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-19T14:02:54Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Doxycycline reduces osteopenia in female rats
title Doxycycline reduces osteopenia in female rats
spellingShingle Doxycycline reduces osteopenia in female rats
Figueiredo, Fellipe A. T. de
title_short Doxycycline reduces osteopenia in female rats
title_full Doxycycline reduces osteopenia in female rats
title_fullStr Doxycycline reduces osteopenia in female rats
title_full_unstemmed Doxycycline reduces osteopenia in female rats
title_sort Doxycycline reduces osteopenia in female rats
author Figueiredo, Fellipe A. T. de
author_facet Figueiredo, Fellipe A. T. de
Shimano, Roberta C.
Ervolino, Edilson [UNESP]
Pitol, Dimitrius L.
Gerlach, Raquel F.
Issa, Joao Paulo M.
author_role author
author2 Shimano, Roberta C.
Ervolino, Edilson [UNESP]
Pitol, Dimitrius L.
Gerlach, Raquel F.
Issa, Joao Paulo M.
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade de São Paulo (USP)
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Figueiredo, Fellipe A. T. de
Shimano, Roberta C.
Ervolino, Edilson [UNESP]
Pitol, Dimitrius L.
Gerlach, Raquel F.
Issa, Joao Paulo M.
description Doxycycline, a member of the tetracycline family, is a drug used as an antibiotic (dosage of 100 mg/day) and as an anti-inflammatory drug on the dosage of 20 mg twice a day, this use has Matrix Metalloproteinases (MMP) inhibitor action. Doxycycline is a calcium chelator and therefore interferes in bone remodeling. The main objective of this study was to evaluate the action of the drug doxycycline in the control of osteopenia. Sixty three Wistars rats were divided into 9 groups with n=7 each, as follow: the control group with doxycycline 10 mg/kg/day (C10), control with doxycycline 30 mg/kg/day (C30) and control (C), ovariectomized group with doxycycline 10 mg/kg/day (OVX10), ovariectomized with doxycycline 30 mg/kg/day (OVX30), and ovariectomized with water (OVX), sedentary group with 10 mg/kg/day (Se10), sedentary with doxycycline 30 mg/kg/day (Se30), and sedentary group with water (Se). Left femoral bone was used for bone densitometry, right femoral bone for histological analysis. The right tibia was intended for chemical quantifications, the total serum was used for cholesterol and calcium quantification. The length of the left femoral bone was measured after the densitometry analysis. Statistical analysis was performed using multivariate general linear model (ANOVA two factors with Bonferroni adjustment) and the TRAP analysis was subjected to normality test and then were subjected to nonparametric test, both with p < 0.05 significance. Statistically significant differences were found, with better results for the groups exposed to the medication (10 and 30 mg/kg/day): Se vs. Se10 and Se vs. Se30 for BMC, quantification of magnesium, amount of cancellous bone in the distal portion; OVX vs. OVX10 for BMC, BMD and calcium in serum; OVX vs. OVX10 and OVX30 for quantification in proximal and distal portion of cancellous bone; Se vs. Se30 and OVX vs. OVX30 for immunostaining for TRAP, all results with minimum of p <= 0.05. Doxycycline had a deleterious effect on control groups and positive action for bone organization on female rats affected by bilateral ovariectomy-induced osteopenia and sedentary lifestyle.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-25
2020-12-10T19:39:23Z
2020-12-10T19:39:23Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1038/s41598-019-51702-y
Scientific Reports. London: Nature Publishing Group, v. 9, 14 p., 2019.
2045-2322
http://hdl.handle.net/11449/196276
10.1038/s41598-019-51702-y
WOS:000492825800026
url http://dx.doi.org/10.1038/s41598-019-51702-y
http://hdl.handle.net/11449/196276
identifier_str_mv Scientific Reports. London: Nature Publishing Group, v. 9, 14 p., 2019.
2045-2322
10.1038/s41598-019-51702-y
WOS:000492825800026
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Scientific Reports
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 14
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1813546449491722240